James Corden admits turning to weight loss drug Ozempic in a bid to slim down
The Gavin and Stacey star has come to the realisation that ‘nothing about my eating has anything to do with being hungry’ ...
James Corden opens up about why he stopped using Ozempic to help him loose weight
James Corden has opened up about his experience using Ozempic for weight loss. The actor, 46, has been incredibly open about ...
WeightWatchers CEO suddenly quits after push to embrace weight-loss drugs like Ozempic, Wegovy
Sima Sistani, who took up the CEO post at WW International two-and-a-half years ago, is out, according to the company.
WeightWatchers' CEO embraced Ozempic. Now she's out of the company.
Sima Sistani helped push the company into the GLP-1 drug space with the $106 million acquisition of Sequence.
Voices: Like James Corden, I also had to give up taking Ozempic – here’s why
COMMENT: As a binge eater, Charlotte Cripps thought the slimming wonder drug would offer a miracle cure for her cravings. She ...
James Corden's shocking Ozempic confession after signing Weight Watchers megadeal
James Corden confessed he tried Ozempic in his bid to lose weight, but revealed the drug that is intended to treat those with ...
Sima Sistani, who embraced Ozempic, is out as CEO of WeightWatchers
WeightWatchers CEO Sima Sistani, who pushed the company into embracing weight-loss drugs, is leaving the position after a two ...
Opinion
Like James Corden, I also had to give up taking Ozempic – here’s why
As a binge eater, Charlotte Cripps thought the slimming wonder drug would offer a miracle cure for her cravings. She found out the hard way that wasn’t to ...
WeightWatchers CEO who oversaw diet company’s move into weight loss drugs abruptly leaves role
WeightWatchers is shaking up its leadership. WW International on Friday announced that CEO Sima Sistani would leave her role ...
WeightWatchers CEO Sima Sistani out in abrupt exit, embraced weight loss drugs
WeightWatchers announced Friday that CEO Sima Sistani is no longer at the company, and independent board member Tara Comonte ...